Evidence map›Paper›PMID 17261752›Full record

ReviewAnnals of the New York Academy of Sciences2006

The role of estrogens in normal and abnormal development of the prostate gland.

Gail S Prins, Liwei Huang, Lynn Birch, Yongbing Pu

Abstract readReview
In one paragraph

Review in Annals of the New York Academy of Sciences, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 51 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
51citing papers in PubMed, 1 pooled it
8.3field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

51 citing papers in PubMed, 1 synthesis or guideline pooled it, 125 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Combined Effects of Different Endocrine-Disrupting Chemicals (EDCs) on Prostate Gland.International journal of environmental research and public health · 2021
    Review
  6. Animal models of benign prostatic hyperplasia.Prostate cancer and prostatic diseases · 2021
    Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Estrogens in Male Physiology.Physiological reviews · 2017
    Review
  13. Review
  14. Compounds fromEvidence-based complementary and alternative medicine : eCAM · 2017
    Article
  15. Article
  16. Murine Prostate Micro-dissection and Surgical Castration.Journal of visualized experiments : JoVE · 2016
    Article
  17. Review
  18. Histone acetylation regulates prostate ductal morphogenesis through a bone morphogenetic protein-dependent mechanism.Developmental dynamics : an official publication of the American Association of Anatomists · 2015
    Article
  19. Article
  20. The role of estrogen receptor β in prostate cancer.Molecular medicine (Cambridge, Mass.) · 2014
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Gail S PrinsDepartment of Urology, University of Illinois at Chicago, 820 South Wood, Chicago, IL 60612, USA. gprins@uic.edu
Liwei Huang
Lynn Birch
Yongbing Pu
University of Illinois Chicago · US

Funding

Development Estrogenization of the Rat Prostate GlandR01DK040890 · NIDDK · UNIVERSITY OF ILLINOIS AT CHICAGO · PI PRINS, GAIL S · 1996 to 2010
$2.9M
ESTROGEN IMPRINTING OF PROSTATE GLAND VIA METHYLATONR21ES012281 · NIEHS · UNIVERSITY OF ILLINOIS AT CHICAGO · PI PRINS, GAIL S · 2003 to 2005
$398k
HORMONAL REGULATION OF RAT PROSTATE STEROID RECEPTORSR29DK040890 · NIDDK · UNIVERSITY OF ILLINOIS AT CHICAGO · PI PRINS, GAIL S · 1989 to 1993
–
NIDDK NIH HHS DK 40890NIDDK NIH HHS R01 DK040890NIEHS NIH HHS R21 ES012281
6 · The paper itself

Abstract

Estrogens play a physiologic role during prostate development with regard to programming stromal cells and directing early morphogenic events. However, if estrogenic exposures are abnormally high during the critical developmental period, permanent alterations in prostate branching morphogenesis and cellular differentiation will result, a process referred to as neonatal imprinting or developmental estrogenization. These perturbations are associated with an increased incidence of prostatic lesions with aging, which include hyperplasia, inflammation, and dysplasia. To understand how early estrogenic exposures can permanently alter the prostate and predispose it to neoplasia, we examined the effects of estrogens on prostatic steroid receptors and key developmental genes. Transient and permanent alterations in prostatic AR, ERalpha, ERbeta, and RARs are observed. We propose that estrogen-induced alterations in these critical transcription factors play a fundamental role in initiating prostatic growth and differentiation defects by shifting the prostate from an androgen-dominated gland to one whose development is regulated by estrogens and retinoids. This in turn leads to specific disruptions in the expression patterns of key prostatic developmental genes that normally dictate morphogenesis and differentiation. Specifically, we find transient reductions in Nkx3.1 and permanent reductions in Hoxb-13, which lead to differentiation defects particularly within the ventral lobe. Prolonged developmental expression of Bmp-4 contributes to hypomorphic growth throughout the prostatic complex. Reduced expression of Fgf10 and Shh and their cognate receptors in the dorsolateral lobes leads to branching defects in those specific regions in response to neonatal estrogens. We hypothesize that these molecular changes initiated early in life predispose the prostate to the neoplastic state upon aging.

Indexed as

AnimalsEstrogensGene Expression Regulation, DevelopmentalHomeodomain ProteinsIntercellular Signaling Peptides and ProteinsMaleMiceProstateProstatic DiseasesProstatic HyperplasiaRatsReceptors, SteroidEstrogensHomeodomain ProteinsIntercellular Signaling Peptides and ProteinsReceptors, Steroid

Identifiers

PMID17261752
PMCPMC2276871
OpenAlexW2164755978

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.